Opus Genetics, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
8 DAVIS DRIVE, DURHAM, NC, 27713
Mailing Address
8 DAVIS DRIVE, DURHAM, NC, 27713
Phone
248-681-9815
Fiscal Year End
1231
EIN
113516358
Financial Overview
FY2025
-$49.59M
Net Income
$50.24M
Total Assets
$49.91M
Stockholders' Equity
$45.09M
Cash & Equivalents
$-0.80
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| DEF 14A Definitive proxy statement | March 23, 2026 | View on SEC |
| 4 Insider stock transaction report | March 18, 2026 | View on SEC |
| 4 Insider stock transaction report | March 18, 2026 | View on SEC |
| 4 Insider stock transaction report | March 18, 2026 | View on SEC |
| 4 Insider stock transaction report | March 18, 2026 | View on SEC |
| S-3 Shelf registration for future offerings | March 13, 2026 | View on SEC |
| 10-K Annual financial report | March 12, 2026 | View on SEC |
| 8-K Current report of material events | March 10, 2026 | View on SEC |
| 8-K Current report of material events | February 19, 2026 | View on SEC |
| 4 Insider stock transaction report | February 17, 2026 | View on SEC |
Annual Reports
10-K
March 12, 2026
- Successfully completed patient enrollment for its lead gene therapy program, IRD-101, with initial efficacy signals anticipated in mid-2026.
- Raised significant capital of $42.5 million in 2025 through private placements, registered direct offerings, and an At-The-Market (ATM) program.
Insider Trading
STRONG SELL
6 insiders
7 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.